Vanda Pharmaceuticals

Vanda Pharmaceuticals will announce its Q4 and full-year 2025 financial results on February 11, 2026. A conference call at 4:30 PM ET will follow, where management will discuss performance, pipeline progress, and corporate developments. Webcast and replay details are available on Vanda’s website. Investors will be assessing the company’s strategy, product performance, and R&D advancements.